Helix Biopharma Corp.
HBP.TO
TSX
| 01/31/2026 | 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -98.34% | 117.24% | -93.99% | 0.15% | 1,437.46% |
| Total Receivables | -21.70% | 7.75% | 123.53% | -63.75% | -50.84% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -58.31% | -1.99% | -30.68% | -18.97% | 53.07% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -93.55% | 66.16% | -71.97% | -10.30% | 574.33% |
|
|
|||||
| Total Current Assets | -93.55% | 66.16% | -71.97% | -10.30% | 574.33% |
| Net Property, Plant & Equipment | -94.66% | -78.46% | -87.50% | -79.35% | -53.87% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 1,936,628.57% | 1,874,485.71% | 1,898,085.71% | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 781.63% | 4,479.33% | 1,160.40% | -12.35% | 502.53% |
|
|
|||||
| Total Accounts Payable | -28.79% | 107.53% | 168.84% | 62.60% | 921.25% |
| Total Accrued Expenses | -56.60% | -26.37% | -20.45% | 68.11% | 183.23% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 49.32% | 67.78% | 103.29% | 58.55% | 246.62% |
|
|
|||||
| Total Current Liabilities | 49.32% | 67.78% | 103.29% | 58.55% | 246.62% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 49.32% | 67.78% | 103.29% | 58.55% | 246.62% |
|
|
|||||
| Common Stock & APIC | 17.18% | 10.90% | 10.31% | 2.97% | -3.98% |
| Retained Earnings | -8.80% | -1.73% | -2.28% | -4.08% | 3.10% |
| Treasury Stock & Other | -13.42% | -26.55% | -16.85% | 53.70% | 77.55% |
| Total Common Equity | 86,548.09% | 1,271.27% | 17,373.01% | -284.08% | 93.23% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 86,548.09% | 1,271.27% | 17,373.01% | -284.08% | 93.23% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 86,548.09% | 1,271.27% | 17,373.01% | -284.08% | 93.23% |
|
|
|||||